-
A small device that gently stimulates nerves through the ear in no better than placebo to tackle stubborn high blood pressure.
Medical Mythbusting Commentary for October 26, 2026 Source:Could lowering high blood pressure be as simple as stimulating your ear?Reference:Safety, Acceptability and Efficacy of Noninvasive Transcutaneous-Autonomic Neuromodulation in Uncontrolled Hypertension
-
Exposure to light at night may be linked to potentially harmful changes in the heart’s structure and performance
Medical Mythbusting Commentary for September 16, 2026 Source:Nighttime Light May Make Your Heart Thicker and Stiffer Reference:Nighttime light exposure and cardiac structure and function
-
Too many confounding factors to conclude that there is an association between melatonin use and increased congestive heart failure risk
Medical Mythbusting Commentary for September 8, 2026 Source:Melatonin Use Linked to Massively Increased Risk of Heart Failure Reference:Long-term melatonin use linked to 90% higher heart failure risk
-
Targeted gene-altering therapy reduced LDL-cholesterol levels by 50 per cent in patients with severely elevated cholesterol levels.
Medical Mythbusting Commentary for September 2, 2026 Source:With the snip of a gene, scientists hope to erase high cholesterol for life Reference:Phase 1 Trial of CRISPR-Cas9 Gene Editing Targeting ANGPTL3
-
Newer understanding of new blood vessel growth after heart attack may lead to treatments to promote better bypass circulation.
Medical Mythbusting Commentary for August 24, 2026 Source:Your Heart Can Actually Build Its Own Bypass After a Heart Attack Reference:Tracing the origins of de novo coronary collateral formation in cardiac repair
-
Phase 1 targeted gene editing study demonstrates safety and reduction in LDL cholesterol levels through specific protein pathway
Medical Mythbusting Commentary for August 17, 2026 Source:‘An extremely exciting milestone!’: landmark treatment slashes cholesterol by 62% with a single dose Reference:In Vivo Base Editing of PCSK9 with VERVE-102 for Hypercholesterolemia
-
Beta-blockers, taken by millions after a heart attack, found to be ineffective for people with uncomplicated heart attacks (normal heart function thereafter) and presents increased risk of harm to women. Changes to management likely in the works for this population.
Medical Mythbusting Commentary for May 27, 2026 Source:Common heart drug taken by millions found useless — and possibly dangerous Reference:Beta-Blockers after Myocardial Infarction without Reduced Ejection Fraction Beta-blockers after myocardial infarction: effects according to sex in the REBOOT trial
-
Remnant cholesterol levels found to be an independent risk factor for heart disease. We discuss what this is and what the approach to management entails.
Medical Mythbusting Commentary for May 26, 2026 Source:Experts have found a new type of cholesterol. And it could be the most dangerous Reference: Source: openevidence.comRemnant cholesterol — defined as total cholesterol minus LDL-C minus HDL-C — is an emerging and increasingly recognized causal risk factor for ASCVD. Management centers on lifestyle modification as first-line therapy,…